Federated Hermes
ORIC icon

Federated Hermes’s Oric Pharmaceuticals ORIC Stock Holding History

Federated Hermes’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-152
Closed -$2.09K – 2107
2024
Q1 		$2.09K Buy
+152
New +$1.8K ﹤0.01% 1921
2023
Q4 		– Sell
-624
Closed -$3.77K – 2161
2023
Q3 		$3.77K Buy
624
+157
+34% +$1.29K ﹤0.01% 1913
2023
Q2 		$3.62K Buy
467
+324
+227% +$1.84K ﹤0.01% 1939
2023
Q1 		$815 Sell
143
-432
-75% -$2.26K ﹤0.01% 2053
2022
Q4 		$3.39K Buy
575
+141
+32% +$476 ﹤0.01% 1963
2022
Q3 		$1K Buy
+434
New +$1.74K ﹤0.01% 2068
2022
Q2 		– Sell
-506
Closed -$3K – 2243
2022
Q1 		$3K Buy
+506
New +$4.56K ﹤0.01% 2002

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return